White House drug strategy endorses treatment but tightens funding for fentanyl test strips

The White House released a new drug‑policy document on May 4 that lists public‑health measures such as wider access to the overdose‑reversal drug naloxone, medication‑assisted treatment, and the distribution of test strips that detect fentanyl in illicit supplies.

Just days earlier, the administration announced tighter restrictions on the use of federal dollars for distributing those test strips and warned that medication‑assisted treatment should only be provided when paired with additional services like counseling.

The paper also emphasizes hard‑line actions, including plans for a wall along the Mexican border, deportations of drug traffickers, and other enforcement tactics, underscoring a mixed signal between harm‑reduction initiatives and stricter enforcement policies.